Cargando…
Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327]
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952812/ https://www.ncbi.nlm.nih.gov/pubmed/29548725 http://dx.doi.org/10.1016/j.redox.2018.03.001 |
| _version_ | 1783323262970757120 |
|---|---|
| author | Kalyanaraman, Balaraman Cheng, Gang Hardy, Micael Ouari, Olivier Lopez, Marcos Joseph, Joy Zielonka, Jacek Dwinell, Michael B. |
| author_facet | Kalyanaraman, Balaraman Cheng, Gang Hardy, Micael Ouari, Olivier Lopez, Marcos Joseph, Joy Zielonka, Jacek Dwinell, Michael B. |
| author_sort | Kalyanaraman, Balaraman |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5952812 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59528122018-05-16 Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] Kalyanaraman, Balaraman Cheng, Gang Hardy, Micael Ouari, Olivier Lopez, Marcos Joseph, Joy Zielonka, Jacek Dwinell, Michael B. Redox Biol Corrigendum Elsevier 2018-03-13 /pmc/articles/PMC5952812/ /pubmed/29548725 http://dx.doi.org/10.1016/j.redox.2018.03.001 Text en © 2018 The Author(s) |
| spellingShingle | Corrigendum Kalyanaraman, Balaraman Cheng, Gang Hardy, Micael Ouari, Olivier Lopez, Marcos Joseph, Joy Zielonka, Jacek Dwinell, Michael B. Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] |
| title | Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] |
| title_full | Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] |
| title_fullStr | Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] |
| title_full_unstemmed | Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] |
| title_short | Corrigendum to 'A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [REDOX 14C (2017) 316–327] |
| title_sort | corrigendum to 'a review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: therapeutic targeting of tumor mitochondria with lipophilic cationic compounds' [redox 14c (2017) 316–327] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952812/ https://www.ncbi.nlm.nih.gov/pubmed/29548725 http://dx.doi.org/10.1016/j.redox.2018.03.001 |
| work_keys_str_mv | AT kalyanaramanbalaraman corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT chenggang corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT hardymicael corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT ouariolivier corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT lopezmarcos corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT josephjoy corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT zielonkajacek corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 AT dwinellmichaelb corrigendumtoareviewofthebasicsofmitochondrialbioenergeticsmetabolismandrelatedsignalingpathwaysincancercellstherapeutictargetingoftumormitochondriawithlipophiliccationiccompoundsredox14c2017316327 |